Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion.
* Furthers Endo's evolution from a product-driven company to a healthcare solutions provider
* Strengthens Endo's leading core urology franchise while diversifying revenue, earnings and cash flow
* Fulfills Endo's strategy to build scale in devices and services business segment
* Transaction expected to be immediately accretive to adjusted diluted earnings per share upon close and accretive by $0.60 in 2012
Endo Pharmaceuticals ENDP and American Medical Systems AMMD announced today that they have entered into a definitive agreement under which Endo will acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt. The combined company will be positioned to deliver more comprehensive healthcare solutions across its diversified businesses in branded pharmaceuticals, generics and devices and services, in the key therapeutic areas of urology and pain.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in